APIM THERAPEUTICS

APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellular responses to DNA damage and stress.

APIM THERAPEUTICS

Industry:

Biotechnology Finance Therapeutics Venture Capital

Founded:

2009-01-01

Address:

Trondheim, Sor-Trondelag, Norway

Country:

Norway

Website Url:

http://www.apimtherapeutics.com

Total Employee:

Status:

Active

Contact:

+47 73 49 4002

Email Addresses:

[email protected]

Total Funding:

3.01 M USD

Technology used in webpage:

SPF Japanese Yen SingleHop

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Employees Featured

marit-otterlei_image

Marit Otterlei
Marit Otterlei Chief Scientific Officer @ APIM Therapeutics
Chief Scientific Officer

konstantinos-alevizopoulos_image

Konstantinos Alevizopoulos
Konstantinos Alevizopoulos CEO @ APIM Therapeutics
CEO
2020-01-01

Founder

marit-otterlei_image

Marit Otterlei

Investors List

investinor_image

Official Site Inspections

http://www.apimtherapeutics.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K

Host Informations
Whois Informations

Loading ...